|
1 Company |
|
2 Products |
|
2 Products |
|
2 Mechanisms of Action |
|
0 Trials |
|
5 News |
|
- | Trial completion: Transversalis Fascial Plane Nerve Block in Iliac Crest Bone Graft (clinicaltrials.gov) - Dec 15, 2017
P=N/A, N=56, Completed, Sponsor: University Health Network, Toronto
Recruiting --> Completed
- Trial initiation date: A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma (clinicaltrials.gov) - Apr 15, 2014
P=N/A, N=29, Completed, Sponsor: Gilead Sciences
Recruiting --> Completed Initiation date: Mar 2013 --> Apr 2013
- | Trial completion: A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma (clinicaltrials.gov) - Apr 15, 2014
P=N/A, N=29, Completed, Sponsor: Gilead Sciences
Initiation date: Mar 2013 --> Apr 2013 Recruiting --> Completed
- | ambrisentan / Generic mfg.
Trial completion: Efficacy of Ambrisentan in Limited Scleroderma Patients in Improving Blood Flow to Hands or Feet (clinicaltrials.gov) - Mar 21, 2013
P=N/A, N=20, Completed, Sponsor: Soumya Chatterjee
Recruiting --> Completed Active, not recruiting --> Completed
- |||| Orenitram (treprostinil diethanolamine oral) / United Therapeutics Corp
Trial completion: DISTOL-1: Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine (clinicaltrials.gov) - Oct 18, 2012
P2, N=148, Completed, Sponsor: United Therapeutics
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment open: Transversalis Fascial Plane Nerve Block in Iliac Crest Bone Graft (clinicaltrials.gov) - Apr 24, 2012
P=N/A, N=56, Recruiting, Sponsor: University Health Network, Toronto
Active, not recruiting --> Completed Not yet recruiting --> Recruiting